# Cancer Health Outcomes and Control Research Program

> **NIH NIH P30** · VANDERBILT UNIVERSITY MEDICAL CENTER · 2022 · $124,453

## Abstract

PROJECT 008 – CANCER HEALTH OUTCOMES AND CONTROL RESEARCH PROGRAM
PROJECT SUMMARY/ABSTRACT
The overarching mission of the Cancer Health Outcomes and Control Research Program (CO) is to foster
research that can engage and reach out to the catchment area community to reduce the public health burden of
cancer across the entire care continuum and to improve health-related outcomes for those at risk for or with a
diagnosis of cancer. This research, which spans basic, clinical and population-based science across the cancer
care continuum. can be broadly categorized into three thematic domains: 1) prevention and early detection; 2)
patient-centered health outcomes during and following cancer treatment; and 3) implementation of healthcare
interventions and policy to improve cancer care delivery and decrease cancer health disparities. CO will conduct
research across these three domains through the following Specific Aims:
Aim 1. Identify and evaluate strategies targeted to cancer prevention and early detection and develop
and test behavioral- and laboratory-based interventions in healthy and at-risk populations
Aim 2. Assess and compare patient-centered outcomes during and following cancer therapy in order to
inform development of treatment strategies that best balance efficacy with toxicity
Aim 3. Develop and implement healthcare interventions and policies on a population, practice or
individual level that improve access to and delivery of care to minimize the burden of cancer in the VICC
catchment area and nationally
Alongside these scientific aims, the Program will develop opportunities to promote intra- and inter-programmatic
research, training and mentorship with engagement of and outreach to the VICC community in a bidirectional
manner to meet its mission.
There are 29 program members from 14 departments and 5 schools with $8.9M in total peer-reviewed funding
and NCI making up 47% ($4.2M). Out of 477 publications, 15% are intra-programmatic and 19% are inter-
programmatic. Members also have 257 collaborative publications with investigators at other NCI-designated
cancer centers.

## Key facts

- **NIH application ID:** 10488774
- **Project number:** 5P30CA068485-27
- **Recipient organization:** VANDERBILT UNIVERSITY MEDICAL CENTER
- **Principal Investigator:** Debra L. Friedman
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $124,453
- **Award type:** 5
- **Project period:** 1998-09-01 → 2025-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10488774

## Citation

> US National Institutes of Health, RePORTER application 10488774, Cancer Health Outcomes and Control Research Program (5P30CA068485-27). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10488774. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*